SHBG

What SHBG Measures

SHBG (sex hormone binding globulin) is a hepatic glycoprotein that binds testosterone, DHT, and estradiol in circulation. Bound hormone is biologically inactive; only free hormone signals at receptors. Because testosterone's binding affinity for SHBG is higher than for albumin, SHBG is the primary regulator of free testosterone availability.

Too-low SHBG (<20 nmol/L in men) often signals insulin resistance, chronic inflammation, or obesity - and can produce misleadingly "normal" total T with very high free T. Too-high SHBG (>60 nmol/L) suppresses bioavailable hormone and is associated with longevity in some studies but can impair symptoms of androgen sufficiency.

What Affects This Biomarker

SHBG is influenced by: insulin sensitivity (low insulin raises SHBG, high insulin lowers it), thyroid status (hyperthyroidism raises it), alcohol intake, liver function, age (slowly rises with age), body fat (higher = lower SHBG), and pharmacologic agents - oral estrogens raise it, testosterone suppresses it.

In the Context of Peptide Protocols

On TRT, SHBG typically drops 30–50% from baseline as exogenous T suppresses hepatic synthesis. This is expected and not intrinsically problematic - but it shifts the free/total T ratio higher, which can affect dosing decisions. Track SHBG alongside total + free T to understand the full picture.

Deep Dive

SHBG is two signals hiding in one number

Most panels print SHBG as a single carrier value, but it is doing two jobs at once, and both matter for tracking. First, it is the mechanical governor of how much testosterone and estradiol actually reach receptors. This is why no free-testosterone number is meaningful without it: nearly every "calculated free testosterone" is derived from total testosterone, SHBG, and albumin, most commonly with the Vermeulen equation (Vermeulen, Verdonck, and Kaufman, Journal of Clinical Endocrinology and Metabolism, 1999). Hold total T constant and change SHBG, and calculated free T moves in the opposite direction. In women the same relationship is usually expressed as the Free Androgen Index, total testosterone divided by SHBG times 100, a core input in PCOS evaluation.

Second, SHBG is one of the most sensitive circulating readouts of what insulin is doing to the liver. Insulin directly suppresses hepatic SHBG production, so the value doubles as a metabolic marker. That is why a low SHBG almost never travels alone: it usually rides with high fasting insulin, central fat, and elevated triglycerides. Reading SHBG only as a "testosterone helper" throws away half of the information it carries.

Why the optimal window is narrower than the lab range

The standard reference interval is wide because it is built from a general population that already includes a large fraction of insulin-resistant people. The tighter target window exists because SHBG at the low end is a leading metabolic warning, not just a hormone-binding quirk. In a landmark prospective analysis, Ding and colleagues (New England Journal of Medicine, 2009) found that low SHBG strongly predicted future type 2 diabetes in both women and men, and their Mendelian randomization analysis using SHBG gene variants suggested the relationship is not merely a bystander association. In practical terms, an SHBG drifting toward the bottom of the "normal" range is worth pairing with a fasting insulin draw before it is dismissed.

The complicating factor is genetics. A meaningful share of person-to-person SHBG variation is inherited through variants in the SHBG gene, so some people simply run naturally high or naturally low. The interpretive rule of thumb: a low SHBG accompanied by normal fasting insulin, normal triglycerides, and lean body composition is more likely constitutional, whereas a low SHBG stacked with those red flags is the metabolic pattern worth tracking over time with a clinician.

What reliably raises versus lowers it

**Tends to raise SHBG:** - Improving insulin sensitivity and losing visceral fat (the mirror image of what suppresses it) - Thyroid hormone, with overt hyperthyroidism producing large increases - Advancing age, which nudges it up gradually - Oral estrogen, because of first-pass liver exposure. Transdermal estrogen barely moves it, a distinction that matters in menopause protocols - Sustained caloric restriction, and, in observational data, higher coffee and fiber intake

**Tends to lower SHBG:** - Hyperinsulinemia, insulin resistance, and visceral adiposity (the dominant driver) - Androgens, especially oral anabolic steroids and danazol, which can drop it sharply - Growth hormone and IGF-1 excess, which suppress hepatic synthesis - Hypothyroidism - Oral or high-dose exogenous testosterone

Testing pitfalls and timing

**Biotin interference is the most common avoidable error.** SHBG is frequently measured on streptavidin-biotin immunoassay platforms, and high-dose biotin supplements (often 5,000 to 10,000 micrograms in hair and nail products) can distort the result. The U.S. FDA has issued a formal safety communication on biotin interference with immunoassays. Holding biotin for 48 to 72 hours before the draw removes the problem.

**Timing is more forgiving than for testosterone.** SHBG has minimal diurnal swing, unlike total testosterone, which peaks in the morning. Because the two are almost always drawn together, still book the morning fasted slot for the testosterone. Fasting also keeps the insulin state consistent, which matters given how insulin-sensitive SHBG is.

**Track trends on one lab and one method.** Immunoassays differ between labs. Also interpret SHBG next to albumin and total testosterone, never in isolation, and treat acute illness or a recent crash diet as a temporary distorter rather than a new set point.

Peptide and protocol tracking context

The single most important protocol nuance is what a suppressed SHBG does to calculated free testosterone. On injectable testosterone, SHBG falls, and a peak total T can push calculated free T to alarming-looking heights mid-cycle. Read in isolation, a single peak can be misleading, so it helps to track free T against trough draws and symptoms over time, and to remember the calculation is only as good as the SHBG feeding it. Any dosing decision belongs with your clinician, not a single number.

The GLP-1 case is the opposite and easy to misread. As semaglutide, tirzepatide, or retatrutide reduce visceral fat and improve insulin sensitivity, SHBG is expected to rise. Because calculated free T moves inversely to SHBG, a person can see free T "fall" on paper while gonadal output has not changed at all. The more accurate read is usually that SHBG rose, not that testosterone production dropped.

Growth-oriented peptides that raise IGF-1, including tesamorelin, CJC-1295 with ipamorelin, and MK-677, can nudge SHBG down through the GH and IGF-1 pathway, so track it alongside IGF-1 and fasting insulin. Across every one of these protocols, the highest-signal practice is to log SHBG in the same view as total testosterone, calculated free testosterone, and fasting insulin. Discuss any sustained shift with your clinician, and use the four together to separate a true hormonal change from a purely metabolic one.

Related Reading

• Testosterone Panel Guide →

Conditions That Track SHBG

Frequently Asked Questions

Where This Fits in Your Panel

SHBG is one marker on a fuller panel. The Peptide Blood Work Checklist lays out the complete baseline panel, what to add by protocol type, and when to retest.

Upload any lab PDF and MyProtocolStack maps your values to SHBG and 40+ other biomarkers. StackAI interprets the trend in context of your protocol.